Honest Broker: Difference between revisions

Jump to navigation Jump to search
m
no edit summary
No edit summary
mNo edit summary
(4 intermediate revisions by 2 users not shown)
Line 7: Line 7:
<td style="padding:0.5em; background-color:#e5e5e5; font-size:90%; line-height:0.95em; border:1px solid #A3B1BF; border-bottom:solid 2px #A3B1BF" width="20">[[Research Compliance]] </td>
<td style="padding:0.5em; background-color:#e5e5e5; font-size:90%; line-height:0.95em; border:1px solid #A3B1BF; border-bottom:solid 2px #A3B1BF" width="20">[[Research Compliance]] </td>
<td style="border-bottom:2px solid #A3B1BF" width="3">&#160;</td>
<td style="border-bottom:2px solid #A3B1BF" width="3">&#160;</td>
<td style="padding:0.5em; background-color:white; line-height:0.95em; border:solid 2px #A3B1BF; border-bottom:0; font-weight:bold;" width="20">[[Compliance]]</td>
<td style="padding:0.5em; background-color:#e5e5e5; font-size:90%; line-height:0.95em; border:1px solid #A3B1BF; border-bottom:solid 2px #A3B1BF" width="20">[[Compliance]]</td>
<td style="border-bottom:2px solid #A3B1BF" width="3">&#160;</td>
<td style="border-bottom:2px solid #A3B1BF" width="3">&#160;</td>
<td style="padding:0.5em; background-color:#e5e5e5; font-size:90%; line-height:0.95em; border:1px solid #A3B1BF; border-bottom:solid 2px #A3B1BF" width="20">[[Privacy/Information Security]]</td>
<td style="padding:0.5em; background-color:white; line-height:0.95em; border:solid 2px #A3B1BF; border-bottom:0; font-weight:bold;" width="20">[[Privacy/Information Security]]</td>
<td style="border-bottom:2px solid #A3B1BF" width="3">&#160;</td>
<td style="border-bottom:2px solid #A3B1BF" width="3">&#160;</td>
<td style="padding:0.5em; background-color:#e5e5e5; font-size:90%; line-height:0.95em; border:1px solid #A3B1BF; border-bottom:solid 2px #A3B1BF" width="20">[[Business Operations]]</td>
<td style="padding:0.5em; background-color:#e5e5e5; font-size:90%; line-height:0.95em; border:1px solid #A3B1BF; border-bottom:solid 2px #A3B1BF" width="20">[[Business Operations]]</td>
<td style="border-bottom:2px solid #A3B1BF" width="3">&#160;</td>
<td style="border-bottom:2px solid #A3B1BF" width="3">&#160;</td>
<td style="padding:0.5em; background-color:#e5e5e5; font-size:90%; line-height:0.95em; border:1px solid #A3B1BF; border-bottom:solid 2px #A3B1BF" width="20">[[Intellectual Property]]</td>
<td style="padding:0.5em; background-color:#e5e5e5; font-size:90%; line-height:0.95em; border:1px solid #A3B1BF; border-bottom:solid 2px #A3B1BF" width="20">[[Intellectual Property]]</td>
<td style="border-bottom:2px solid #A3B1BF" width="3">&#160;</td>
<td style="padding:0.5em; background-color:#e5e5e5; font-size:90%; line-height:0.95em; border:1px solid #A3B1BF; border-bottom:solid 2px #A3B1BF"
width="20">[[Faculty]]</td>
</tr>
</tr>
</table>
</table>
Line 65: Line 68:
:*Ascertain their interest in study participation; and
:*Ascertain their interest in study participation; and
:*Obtain written authorization to share their interest in study participation with the investigators and allow patients to be contacted by researcher. The honest broker would not directly contact the patient.
:*Obtain written authorization to share their interest in study participation with the investigators and allow patients to be contacted by researcher. The honest broker would not directly contact the patient.
:*After secondary review by the Associate Vice Chancellor for Clinical Research, an honest broker may provide the research investigator with a list of potentially eligible patients who have agreed to be contacted for research studies they are eligible for based on their election on the Conditions of Treatment form or consistent with the Human Research Protection Program Policy #3.4 “Use of Protected Health Information in Research and Registries” for further information.
:*After secondary review by the Associate Vice Chancellor for Clinical Research, an honest broker may provide the research investigator with a list of potentially eligible patients who have agreed to be contacted for research studies they are eligible for based on their election on the Conditions of Treatment form or consistent with the Human Research Protection Program Policy #3.4 “Use of Protected Health Information in Research” for further information.
*Honest broker Data Requests: Individuals requesting PHI or de-identified data shall complete:
*Honest broker Data Requests: Individuals requesting PHI or de-identified data shall complete:
:*the [https://unmcredcap.unmc.edu/redcap/surveys/?s=94TLJCCAAT UNMC/Nebraska Medicine Request for Electronic Health Data Form] (research),  
:*the [https://unmcredcap.unmc.edu/redcap/surveys/?s=94TLJCCAAT UNMC/Nebraska Medicine Request for Electronic Health Data Form] (research),  
Line 102: Line 105:
::*An individual honest broker for the investigator must obtain (and retain) evidence of an appropriately executed Data Use Agreement in order to be granted access to the UNMC/Nebraska Medicine-held PHI.
::*An individual honest broker for the investigator must obtain (and retain) evidence of an appropriately executed Data Use Agreement in order to be granted access to the UNMC/Nebraska Medicine-held PHI.
==Additional Information==
==Additional Information==
*Contact the [mailto:debrbishop@nebraskamed.com Privacy Officer]
*Contact the [mailto:debrbishop@nebraskamed.edu Privacy Officer]
*[http://www.unmc.edu/hipaa/about/notice-privacy-practices.html Notice of Privacy Practices]
*[http://www.unmc.edu/hipaa/about/notice-privacy-practices.html Notice of Privacy Practices]
*[http://www.unmc.edu/hipaa/_documents/application-for-honest-broker-certification.pdf Application for Honest Broker Certification Form]
*[http://www.unmc.edu/hipaa/_documents/application-for-honest-broker-certification.pdf Application for Honest Broker Certification Form]

Navigation menu